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The WHO-ILAR collaborative program on rheumatic
disease (COPCORD) includes all musculoskeletal disease
(RD). Studies have now been completed in many developing
countries, and a number of population samples have been
studied in China, India, the Philippines, and Iran [1]. These
have shown that low back pain, knee, neck, and arm pain
are the most common RD as is also the case in developed
countries [2]. Knee osteoarthritis is a major problem,
whereas hip osteoarthritis is rare. Rheumatoid arthritis
prevalence in developing countries is about half that of
developed countries. In Han Chinese, osteoarthritis knee
and low back pains are more common in north China than
in the south and in migrants in Malaysia near the equator
[3]. This is paralleled by radiological changes, so it is not
simply explained by increased pain sensitivity to cold.
World Health Organization estimates of the burden of
disease expressed as disability adjusted life years (DALYS)
are summarized by Brooks [2]. DALYS are the sum of
disability years lost due to disability and years of life lost
due to mortality, so DALYS would underestimate the
relative burden of low mortality disorders such as RD.
Thus, RD deserves a much higher priority than currently
recognized by WHO and in many national health plans. RD
is the most prevalent category of disease in the Bighwan
COPCORD study [4]. This study is unique, as it has been
continued prospectively for 12 years with sustained efforts
to improve the prevention, control, and care of RD.
A great deal of information has accumulated in the
COPCORD studies. Though this would have been used
locally to promote health care for RD, it is now necessary
to take an overview of the data with respect to all
developing countries. We have no COPCORD data from
Sub-Saharan Africa where the problems are formidable and
resources are minimal.
There is an increasing opportunity for the prevention of
RD [5, 6]. This will depend mainly on education, which
should cost less than treatment and rehabilitation.
The major question now is how to raise the level of
control of RD in a cost-effective manner, bearing in mind
the limited economic and skill resources of developing
countries. Chronic disabling conditions impair ability to
progress in education and to be efficient in the work force
and require support from fit members of society, as with
care of the aged. This has been demonstrated by economists
[7, 8]. They argue that an increase in life expectancy as a
result of exogenous health interventions means that more
people must share a limited supply of resources. Doubling
life span could mean that double the number would have to
share the limited amount of food with a decrease in health,
economic level, and a rise in poverty. Contrary to expect-
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ations, they found that the control of fatal diseases, by
increasing population, especially the aged, reduces per
capita income.
By contrast, control of usually non-fatal chronic dis-
abling disease can have a positive impact on average
income. This has been demonstrated with the control of
hookworm [9] and with malaria [10].
By analogy, it would be expected that control of RD
would also raise the standard of living and improve overall
productivity and quality of life without increasing the
population. To test this hypothesis, it is planned to compare
available economic indicators in Bhigwan village in India
before and after 12 years of intervention against RD. A
comparison would also be made with the contemporaneous
economic status in a similar village where there has been no
such intervention.
Obviously control of other diseases, particularly infections,
will have to continue. Welfare support in food and finance has
only a temporary effect and may not reach the most
disadvantaged but will still be needed as well as efforts to
control population expansion in developing countries.
Disclosures None.
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